Glycosylation patterns of mucins in colonic disease
Glycosylation patterns of mucins in colonic disease
复制标题
DOI:
10.1042/bst0230840
复制
发表时间:
1995-11-01
影响因子:
3.9
通讯作者:
Paraskeva, C
中科院分区:
文献类型:
--
作者:
Corfield, AP;Myerscough, N;Paraskeva, C
The mucins synthesized and secreted by the mucosal cells lining the gastrointestinal tract form a vital part of the total mucosal secretion giving rise to the extracellular barrier. The supramucosal barrier forms the primary line of defence for the mucosa against attack from the external environment, including all manner of micro-organisms, biochemical agents and mechanical stresses. Mucins from each section of the gastrointestinal tract have a typical carbohydrate and mucin gene product composition reflecting their function at each location [1, 2]. Both the secreted mucins, forming the extracellular gels [3], and cell membrane-associated (glycocalyx) mucins, typically MUC1 type and involved in cell-surface interactions [4], are implicated in the cell-surface and supramucosal layer changes occurring during gastrointestinal cancer and inflammatory bowel diseases such as ulcerative colitis (UC)[2, 5]. In addition, enzymes secreted by the normal enteric bacterial flora continually degrade mucins in the mucosal barrier in a controlled manner, allowing an equilibrium to be maintained between synthesis, secretion, degradation and an efficient protective function. Modifications in the structure of the mucosal barrier mucins influence the rate of degradation and therefore the viability of the defensive barrier.